Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adacel vs Boostrix in US Adolescents
NCT00319553Phase 4Completed
- Sponsor
- Sanofi
- Start
- May 2006
- Primary completion
- Oct 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of acellular pertussis vaccine in Tetanus, diphtheria and pertussis (2 arms), sponsored by Sanofi. Primary endpoints: Number of Participants Reporting A Solicited Injection Site or Systemic Reactions, Percentage of Participants With Tetanus Antitoxin Concentrations >= 0.1 IU/mL at Day 28 and 2 more. Started May 2006; status: completed.
02
Drugs
acellular pertussis vaccine
03
Conditions
Tetanusdiphtheriapertussis
Beyond the preview
Go deeper on NCT00319553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00319553.